A New Approach to Precision Medicine

A New Approach to Precision Medicine

Over the last decade, artificial intelligence (AI) has revolutionised patient care significantly, enhancing diagnostic accuracy, treatment personalisation, and overall healthcare efficiency. In recent times, the healthcare ecosystem has also witnessed a greater integration of AI into oncology as well. This has enabled healthcare providers to leverage real-time data and predictive analytics, making informed decisions that propel advancements in medical care for cancer patients.Cancer is a highly heterogeneous disease, with each patient presenting a unique genetic and molecular profile. Continuous and timely monitoring is critical for cancer patients, who are at higher risk of clinical deterioration.

Medigy Insights

AI’s ability to process and analyse complex datasets allows for the development of treatment plans tailored to an individual’s specific cancer type and genetic makeup. This personalised approach not only has the potential to enhance treatment efficacy but also can minimise adverse effects, leading to better patient outcomes.As per the Global Market Insights report, AI in the oncology market is projected to reach $7.6 billion by 2032 driven by rising adoption of AI in cancer diagnosis and treatment. In 2023, the oncology diagnostics segment was valued at $341.4 million.




Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on Sep 20, 2024 at 12:08pm